Avalyn Pharma Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | +16.7% | +28.0% | +8.0% | |
| – | +14.7% | +28.9% | +30.7% | |
| – | +16.4% | +28.2% | +11.7% | |
| – | – | – | – | |
| – | – | – | +177.6% | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.